Answerthink, Inc. (NASDAQ: ANSR), announced today that Holopack International has selected EzPharma, an SAP� All-in-One solution from Answerthink that is preconfigured with best practices and functionality specifically for growing pharmaceutical delivery and manufacturing companies. Holopack is a leading innovator of liquid pharmaceutical delivery systems headquartered in Columbia, SC. The company�s liquid dose drug delivery systems allow for quick, portable, and sterile delivery of medications and other products. Holopack�s vision was to select and install a �user friendly� solution that would allow all users to access common on-line, real-time information. When the system is fully installed, it will result in financial, operational, and customer service improvements. These improvements should include enhanced system support for managing sales orders, production planning and scheduling, materials planning, lot traceability, and distribution requirements planning. Holopack also anticipates using the system to facilitate an enhanced environment. "SAP will provide Holopack the needed platform to maximize our manufacturing and product development processes,� said Mohammad Sageghi, VP for Holopack. �Answerthink is assisting us to raise the bar to even greater heights while exceeding our expectations in both customer service and implementation.� According to Answerthink SAP Solutions Group Managing Director John McGrath, "We're delighted to be working with Holopack. We believe that our EzPharma solution will provide superior value to a growing, innovative customer, like Holopack. Many small and midsize companies are coming to the conclusion that they can take on world-class software from SAP if a preconfigured, industry-based approach is used." Answerthink is a strategic business and technology consulting firm that enables companies to achieve world-class business performance. SAP All-in-One solutions are industry-specific software, implementation, and training solutions developed by SAP partners using SAP applications. EzPharma is an industry-specific offering from Answerthink based on best practices from SAP and customized for growing companies in pharmaceutical manufacturing industries. It is part of Answerthink�s EzLifeSciences family of preconfigured solutions that are designed specifically to help life sciences companies achieve goals such as streamlined product development, manufacture reporting automation, and regulatory compliance, and supporting critical business processes. Holopack is one of thirteen life sciences companies that has selected SAP, Answerthink and EzLifeSciences within the past 12 months. About Answerthink Answerthink, Inc. (www.answerthink.com) is a leading business and technology consulting firm that enables companies to achieve world-class business performance. By leveraging the comprehensive database of The Hackett Group, Answerthink's business and technology solutions help clients significantly improve performance and maximize returns on technology investments. Answerthink's capabilities include benchmarking, business transformation, business applications, business intelligence, and offshore application development and support. Founded in 1997, Answerthink has offices throughout the United States and in Europe and India. Answerthink was named the 2006 SAP SME Partner of the Year. Copyright � 2007 Answerthink, Inc. All rights reserved. Answerthink, EzPharma and EzLifeSciences as well as their respective logos are trademarks or registered trademarks of Answerthink, Inc. Copyright � 2007 SAP AG. All rights reserved. SAP, R/3, SAP, SAP.com, xApps, xApp, SAP NetWeaver and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP AG in Germany and in several other countries all over the world. All other product and service names mentioned are the trademarks of their respective companies. Data contained in this document serves informational purposes only. National product specifications may vary. This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and involve known and unknown risks, uncertainties and other factors that may cause Answerthink's actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by the forward-looking statements. Factors that impact such forward-looking statements include, among others, the ability of the products, services, or practices mentioned in this release to deliver the desired effect, our ability to effectively integrate acquisitions into our operations, our ability to attract additional business, our ability to effectively market and sell our transformation advisory product offerings and other services, the timing of projects and the potential for contract cancellations by our customers, changes in expectations regarding the information technology industry, our ability to attract and retain skilled employees, possible changes in collections of accounts receivable, risks of competition, price and margin trends, changes in general economic conditions and interest rates as well as other risks detailed in the Company's Annual Report on Form 10-K for the fiscal year ended December 29, 2006 filed with the Securities and Exchange Commission. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
Answerthink (NASDAQ:ANSR)
Historical Stock Chart
From Jul 2024 to Aug 2024 Click Here for more Answerthink Charts.
Answerthink (NASDAQ:ANSR)
Historical Stock Chart
From Aug 2023 to Aug 2024 Click Here for more Answerthink Charts.